Capecitabine vs 5‐FU‐containing regimens
Treatment‐related death · people with advanced gastric cancer
It is very uncertain whether capecitabine changes treatment‐related death compared with 5‐FU‐containing regimens (very low certainty).
1 finding from 1 review
- OR 1.88 [0.23, 15.15]2 studies · 481 participantsVery low